Cleo Diagnostics to start analytical validation of ovarian cancer test
Cleo Diagnostics says it will commence analytical validation of its pre-surgical ovarian cancer blood test after receiving the first production batch of 125 commercial test kits made by US-based Bio-Techne.
Cleo Diagnostics ASX:COV is set to commence analytical validation (AV) of its pre-surgical ovarian cancer blood test following receipt of the first production batch of 125 commercial test kits manufactured by US-based Bio-Techne.Delivery of the batch, which follows the completion of the assay devel…